|
Volumn 24, Issue 9, 2009, Pages 106-107
|
FDA notifications. FDA approves raltegravir for HIV-1 treatment-naive patients.
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
2 PYRROLIDONE DERIVATIVE;
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
RALTEGRAVIR;
ADULT;
ARTICLE;
DRUG APPROVAL;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LEGAL ASPECT;
UNITED STATES;
ADULT;
ANTI-HIV AGENTS;
DRUG APPROVAL;
HIV INFECTIONS;
HIV-1;
HUMANS;
PYRROLIDINONES;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
EID: 77951672581
PISSN: 08870292
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (16)
|
References (0)
|